Pharma Industrial India Newsletter [ 2024-08-16]

Open in new window

Pharmaindustrial Mediakit Articles Interviews Appointments Events Magazines

Featured News

LTS Partners with GRAM to Develop Wearable Injector Devices

Sorrel is a next-generation on-body delivery system for large-volume and/or viscous drug formulations designed for patient convenience and pharmaceutical efficiency.

Getinge Rolls Out Operating Room Table and Surgical Light

Getinge has rolled out Maquet Corin, a state-of-the-art operating room (OR) table, and Maquet Ezea, an easy-to-use surgical light.

Lobe Sciences Establishes Wholly Owned Subsidiary Alera Pharma

Alera will be assigned the intellectual property rights focused on the company’s neurological assets and its new chemical entity Psilocin Mucate.

Lupin Secures Tentative Approval from FDA for Brimonidine Tartrate Ophthalmic Solution

Lupin has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Brimonidine Tartrate Ophthalmic Solution, 0.025 percent...

Wanbury Appoints Prakash Venkatraman as President of API Business

Wanbury Ltd. has appointed Prakash Venkatraman as President of the API business.

LSPedia, Pharma Logistics to Advance Pharmaceutical Reverse Logistics

LSPedia has signed a strategic partnership with Pharma Logistics, the industry leader in pharmaceutical reverse distribution.

Champalimaud Foundation to Leverage Lonza Platform to Advance Cell Therapy

Champalimaud Foundation, a biomedical clinical research organization carrying out research and cutting-edge clinical development and discoveries that benefit people, and Lonza have announced the installation...

Evotec Announces Progress in its Collaboration with Bristol Myers Squibb

Evotec and Bristol Myers Squibb entered their strategic neuroscience collaboration in December 2016 to identify disease-modifying treatments for a broad range of neurodegenerative diseases where there...

Alembic Pharma Secures US FDA Approval for Acitretin Capsules

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Soriatane Capsules, 10 mg, 17.5 mg, and 25 mg, of Stiefel Laboratories, Inc. (Stiefel).

Amneal Pharma Gets US FDA Approval for CREXONT Extended-Release Capsules

CREXONT is a novel, oral formulation of carbidopa/levodopa (CD/LD) that combines both immediate-release (IR) granules and extended-release (ER) pellets.

WCG Acquires Array to Develop Integrated Clinical Research Training Solution

WCG has announced the acquisition of Array, a leading content engagement partner for life sciences events that offers a unique combination of data, technology, and engagement services proven to enhance...

Lupin Gets Approval from US FDA for Prednisolone Acetate Ophthalmic Suspension

Lupin has secured approval from US FDA for its Abbreviated New Drug Application (ANDA) for Prednisolone Acetate Ophthalmic Suspension USP, 1 percent to market a generic equivalent of Pred Forte Ophthalmic...

Antengene Gets Malaysian Regulatory Agency Approval for XPOVIO Commercialization

Antengene has announced that Malaysian National Pharmaceutical Regulatory Agency has approved a New Drug Application (NDA) for XPOVIO (selinexor).

Alembic Pharma Gets USFDA Final Approval for Nelarabine Injection

Alembic Pharmaceuticals has secured final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nelarabine Injection, 250 mg/50 mL (5 mg/mL)...

Merck Acquires Mirus Bio to Advance Viral Vector Bioprocessing

Merck has completed the acquisition of Mirus Bio for approximately USD 600 million (around EUR 550 million), following regulatory clearances and the fulfillment of other customary closing conditions.

Acumen Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug

Acumen Pharmaceuticals, Inc. has announced that the first subject has been dosed with a subcutaneous formulation of sabirnetug (ACU193) in a Phase 1 pharmacokinetic (PK) comparison study.

Revolutionizing Pharmaceuticals: How Deep Tech is Transforming Drug Discovery, Manufacturing, and Distribution

The pharmaceutical industry is experiencing a transformative shift with the infusion of advanced technologies into its core operations. From drug discovery...

The Double-Edged Sword of Online Pharmacies: Balancing Access and Security in the Digital Age

In an era where digital convenience reigns supreme, online pharmacies have revolutionized healthcare delivery. These platforms offer unprecedented access to...

TechInvention Sets Benchmark for Automated and Digitalized Vaccine Manufacturing Processes

Q: How does TechInvention ensure the quality, efficacy, and safety of the vaccines produced at the facility? Syed Ahmed: TechInvention is dedicated to helping...

This message and any attachments are confidential and privileged and intented for the use of the addressee only. If you have received this communication in error, please notify the sender by replay e-mail and delete this message from your system. Please note that Internet e-mail guarantees neither the confidentiality nor the proper receipt of the message sent. The data deriving from our correspondence with you are included in a file of OMNIMEDIA, S.L. which exclusive purpose is to manage the communications of the company; under the understanding that, in maintaining said correspondence, you authorize the treatment of such data for the mentioned purpose. You are entitled to exercise your rights of access, rectification, cancellation and opposition by addressing such written application to address C/ Pollensa, 2, Edif. Artemisa of. 12 de LA ROZAS (28290 - MADRID) enclosing your NIF or identifying document photocopies of.

Unsubscribe